Chlamydia Incidence in Respiratory infeCtions sUrvey Study

Recruiting

• Conditions: 10008555; 10024970; Pneumonia; Lung infection

• Registration Number: NL-OMON55017
• Lead Sponsor: Zuyderland Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 408

Inclusion Criteria

- Adult
- Pneumonia defined by a new pulmonary infiltrate on chest radiograph described
by the attending physician, in combination with at least two of the following
criteria: cough, sputum production, temperature > 38.0 °C or < 35.0°C,
auscultatory findings consistent with pneumonia, C-reactive protein
concentration > 15 mg/l, and white blood cell count > 10 x 109 cells/l or < 4 x
109 cells/l or > 10% of rods in leukocyte differentiation.
- Active sputum production

Exclusion Criteria

None

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary: incidence of eleven Chlamydia species in deep respiratory secretions. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary: incidence of eleven Chlamydia species faecal samples. Tertiary:<br /><br>level of agreement between between deep respiratory secretions and faecal<br /><br>samples. comparison between animal contact between patients with our without<br /><br>chlamydial infection. Comparison between patient characteristics of patients<br /><br>with or without chlamydial infection. Comparison between clinical outcomes of<br /><br>patients with or without chlamydial infection. </p><br>